Home
Contact Us
About Us
Advertise
Biotech
Finance
Tech News
Disclaimer
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
BioPharmaJournal
Home
Contact Us
About Us
Advertise
Biotech
Argentina Makes An Official Announcement Of The COVID-19 Vaccine Supply Deal…
Atossa Therapeutics Inc (NASDAQ: ATOS) Granted Regulatory Approval To Open Clinical…
Sorrento Therapeutics Inc (NASDAQ: SRNE), Receives FDA Nod For Clinical Study…
Sigilon Therapeutics Inc (NASDAQ: SGTX) Phase 1/22 Study of SIG-OO1 Placed…
Galectin Therapeutics Inc. (NASDAQ: GALT) Announces Results From Phase 1b Clinical…
Finance
Brooklyn Immunotherapeutics Inc (NYSEAMERICAN:BTX) Clinches An Exclusive License mRNA Gene Editing…
Amarin Corporation Plc (NASDAQ:AMRN) Receives Marketing Authorization For Icosapent Ethyl From…
Hollywall Entertainment Inc (OTCMKTS:HWAL): Under-the-Radar NFT Star in the Making? (PLBY,…
GeoVax Labs (GOVX) surges on positive sentiment
Compass Pathways (CMPS) could lead psychedelic sector
Tech News
Tauriga Sciences Inc (OTCMKTS:TAUG) Could React on New Aegea Rapid Test…
Micro and Macro Tailwinds Converge for KULR
ISWH and the Rebirth of the Crypto Cycle
Disclaimer
Home
Biotech
Biotech
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Argentina Makes An Official Announcement Of The COVID-19 Vaccine Supply Deal With Moderna Inc (NASDAQ: MRNA)
Gavins Felicity
-
July 23, 2021
Atossa Therapeutics Inc (NASDAQ: ATOS) Granted Regulatory Approval To Open Clinical Study of AT-H201 in Australia
Sorrento Therapeutics Inc (NASDAQ: SRNE), Receives FDA Nod For Clinical Study of Phase 2 of RTX For Treating osteoarthritis of the knee pain (OAK)
Sigilon Therapeutics Inc (NASDAQ: SGTX) Phase 1/22 Study of SIG-OO1 Placed On Hold
Galectin Therapeutics Inc. (NASDAQ: GALT) Announces Results From Phase 1b Clinical Trial
Mind Medicine (MindMed) Inc (NASDAQ: MNMD) and Datavant strike a New...
Kate Hudson
-
July 16, 2021
0
Trevena Inc (NASDAQ: TRVN) and Jiangsu Nhwa Pharmaceutical Pronounce the Enrollment...
Gavins Felicity
-
July 15, 2021
0
TapImmune Inc. Common Stock (NASDAQ: MRKR) Announced The Completion Of The...
Gavins Felicity
-
July 14, 2021
0
Evogene Ltd’s (NASDAQ: EVGN) AgPlenus Ltd., Subsidy Has Announced That It...
admin
-
July 13, 2021
0
iBio, Inc. (NYSE:IBIO) Takes a New Step to Enhance its New...
Gavins Felicity
-
July 12, 2021
0
Kintara Therapeutics Inc (NASDAQ: KTRA) Posts Topline Read Out Of Phase...
Matt Wade
-
July 9, 2021
0
Affimed NV (NASDAQ: AFMD) Reports A Stellar Growth Of 129.41% In...
Kate Hudson
-
July 8, 2021
0
Vistagen Therapeutics Inc (NASDAQ: VTGN) Reports Revenues Of $1.1 Million From...
Kate Hudson
-
July 7, 2021
0
Citius Pharmaceuticals Inc (NASDAQ: CTXR) To Continue Phase 3 Pivotal Superiority...
Kate Hudson
-
July 6, 2021
0
The USPTO Grants An Innovative Composition Of Matter Patent To Alterity...
admin
-
July 5, 2021
0
1
2
3
...
91
Page 1 of 91
.td-post-views{ display: none !important; }
